
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos) - 2
New studies of old dogs help scientists understand where they came from - 3
Vote In favor of Your Favored Sort Of Bevarage - 4
U.S. overhauls childhood vaccine schedule, recommends fewer shots - 5
6 Objections for an Ocean side Wedding
Doctored NXT Summit footage falsely portrays Modi as declaring war on Iran and Pakistan
Last Christmas, 3 million viewers watched a Chiefs love story — will Bills fans fall just as hard this year?
Top 20 Compelling Business Books for Progress
Scientists captured female sperm whales on video working together during a birth to protect the calf
Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
2023's Best 10 Cell phone Advancements You Can't Miss
China's 'Venice Of The East' Is A Historic Canal City Near Shanghai With Arched Bridges And Lantern-Lit Waterways
Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs













